$3.00
-0.18-5.66%
가까이에: Nov 20, 4:00 PM EST
$2.99
-0.01-0.33%
시간외: 6:41 PM EST

The average analyst price target for Starling Oncology is $9.25, 209.4% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $8 to $10. The latest change came on Nov 6, 2026, when Lake Street lowered its price target on Starling Oncology from $10 to $8 and kept a Buy rating.
Price Target Range — 1 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months